Entwodiksyon ak aplikasyon CAS:1417997-93-3|HDAC8-AN-1/MDK-7933/22d
Bioaktif HDAC8-IN{-1 se yon inibitè HDAC8 ak yon valè IC50 27.2nM.
Sib HDAC827.2nM (IC50)
Etid in vitroHDAC8-IN-1se yon inhibitor HDAC8 ak yon IC50 nan 27.2nMincancercelllinChemicalbooks.HDAC8-IN-1(compound22d)montre efè antiproliferatif nan plizyè liy selil kansè nan poumon (A5491,}H1291,}) ; 12}}AN-
Spesifikasyon CAS:1417997-93-3|HDAC8-AN-1/MDK-7933/22d
|
ATIK |
SPESIFIKASYON |
|
KAS |
1417997-93-3 |
| mf | C22H19NO3 |
|
mw |
345.39 |
|
Pwen bouyi |
nati |
|
Aparans |
Poud |
|
Pite |
99% |
| Dansite | 1?+-.0.06 g/cm3(Prevwa) |
|
Kondisyon depo |
Sere nan -20 degre |
| Pwodiksyon | Lachin |
Pake ak transpò nan CAS:1417997-93-3|HDAC8-AN-1/MDK-7933/22d
Pake: 1g, 10g, 25g 100g
Transpò: pa courrier / pa lè / pa lanmè



Baj popilè: cas:1417997-93-3|hdac8-nan-1/mdk-7933/22d, Lachin cas:1417997-93-3|hdac8-nan-1/mdk-7933/22d manifaktirè, faktori












